World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
55
Citations
13159
World Ranking
2261
National Ranking
56

Thomas J. Gonda publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Thomas J. Gonda sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 166 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Thomas J. Gonda D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas J. Gonda sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 55 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Thomas J. Gonda is affiliated with the University of South Australia in Australia. Their research primarily focuses on biochemistry, genetics, and molecular biology, with significant contributions to medicine. The scientist's work spans several subfields including molecular biology, hematology, oncology, cancer research, and genetics.

The main topics covered by their research include:

  • Acute Myeloid Leukemia Research
  • Cancer-related Molecular Pathways
  • RNA modifications and cancer
  • Epigenetics and DNA Methylation
  • Cancer Genomics and Diagnostics
  • Ubiquitin and proteasome pathways
  • Histone Deacetylase Inhibitors Research

Thomas J. Gonda has published in a variety of scientific venues, with multiple papers appearing in prestigious journals and platforms, including:

  • Nature Communications
  • Blood
  • Cell Reports
  • Oncogene
  • bioRxiv (Cold Spring Harbor Laboratory)

Their recent papers reflect ongoing research interests and contributions to hematology and cancer fields. Notable papers include:

  • "Nuclear stabilization of p53 requires a functional nucleolar surveillance pathway," 2022, Cell Reports
  • "C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia," 2021, Oncogene
  • "Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia," 2022, Nature Communications
  • "Childhood acute myeloid leukemia shows a high level of germline predisposition," 2021, Blood
  • "Nuclear stabilisation of p53 requires a functional nucleolar surveillance pathway," 2021, bioRxiv (Cold Spring Harbor Laboratory)

Thomas J. Gonda has collaborated frequently with a select group of co-authors, reflecting sustained research partnerships. The most frequent co-authors include:

  • Débora A. Casolari
  • Richard J. D'Andrea
  • Saumya E. Samaraweera
  • Paul Leo
  • Kyaw Ze Ya Maung

Best Publications

  • A family of cytokine-inducible inhibitors of signalling

    Robyn Starr;Tracy A. Willson;Elizabeth M. Viney;Leecia J. L. Murray

  • MYB function in normal and cancer cells.

    Robert G. Ramsay;Thomas J. Gonda

  • Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene

    Hiroshi Sakura;Chie Kanei-Ishii;Takahiro Nagase;Hideki Nakagoshi

  • A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor.

    G. R. Johnson;T. J. Gonda;D. Metcalf;I. K. Hariharan

  • PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models

    K Dredge;E Hammond;P Handley;T J Gonda

  • Role and potential for therapeutic targeting of MYB in leukemia.

    D R Pattabiraman;T J Gonda

  • Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.

    Yvette Drabsch;Honor Hugo;Rui Zhang;Dennis H. Dowhan

  • Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes.

    D. D. L. Bowtell;S. Cory;G. R. Johnson;T. J. Gonda

  • Directly targeting transcriptional dysregulation in cancer

    Thomas J. Gonda;Robert G. Ramsay

  • Molecular Cloning Reveals that the p160 Myb-Binding Protein Is a Novel, Predominantly Nucleolar Protein Which May Play a Role in Transactivation by Myb

    Fiona J. Tavner;Richard Simpson;Shigeki Tashiro;Diane Favier

  • Activation of c-myb by carboxy-terminal truncation: relationship to transformation of murine haemopoietic cells in vitro.

    T J Gonda;C Buckmaster;R G Ramsay

  • The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy

    Keith Dredge;Edward Hammond;Kat Davis;Cai Ping Li

  • Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes

    Diwakar R. Pattabiraman;Crystal McGirr;Konstantin Shakhbazov;Valerie Barbier

  • Activating point mutations in the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of beta subunit dimerization and cell type-specific molecules in signalling.

    B. J. Jenkins;R. D'Andrea;T. J. Gonda

  • Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper.

    T Nomura;N Sakai;A Sarai;T Sudo

  • Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa.

    R G Ramsay;M A Thompson;J A Hayman;G Reid

  • Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb

    Liang Zhao;Evgeny A. Glazov;Diwakar R. Pattabiraman;Faisal Al-Owaidi

  • Targeting c-Myb expression in human disease

    Robert G Ramsay;Anna L Barton;Thomas J Gonda

  • The use of hybridization analysis with complementary DNA to determine the RNA sequence homology between strains of plant viruses: its application to several strains of cucumoviruses.

    Thomas J. Gonda;Robert H. Symons

  • Long-term exposure to retrovirally expressed granulocyte-colony-stimulating factor induces a nonneoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice.

    Juliana M. Chang;Donald Metcalf;Thomas J. Gonda;Gregory R. Johnson

Frequent Co-Authors

Robert G. Ramsay
Robert G. Ramsay Peter MacCallum Cancer Centre
Brian Gabrielli
Brian Gabrielli University of Queensland
Brendan J. Jenkins
Brendan J. Jenkins Hudson Institute of Medical Research
Andrew C. Perkins
Andrew C. Perkins Monash University
Erik W. Thompson
Erik W. Thompson Queensland University of Technology
Angel F. Lopez
Angel F. Lopez University of South Australia
Leonie K. Ashman
Leonie K. Ashman University of Newcastle Australia
Emma L. Duncan
Emma L. Duncan King's College London
Matthew A. Brown
Matthew A. Brown Guy's and St Thomas' NHS Foundation Trust

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology often opens doors to diverse online degree options and career pathways. Many students seek flexible learning from non profit colleges to ensure both affordability and quality education. These accredited institutions offer online programs that fit a variety of schedules and career goals.

If you are an active-duty service member or a veteran, selecting one of the best online colleges for military can provide unique resources, support, and flexible pacing for your academic journey. Such colleges understand the distinctive needs of military students pursuing degrees in STEM and biomedical sciences.

Interested in intersecting fields? Degrees like an online masters in social work or an accelerated masters in psychology online enable students to blend molecular science with human services and mental health careers. This multidisciplinary expertise is increasingly valuable, opening new roles in research, healthcare, and beyond.

Best Scientists Citing Thomas J. Gonda

Trending Scientists

Recently Published Articles